A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(U.S. and German Sourced) in Healthy Chinese Male Subjects
Clinical trial NCT02581748 · COMPLETED
Trial details
- NCT number
- NCT02581748
- Sponsor
- Shanghai Henlius Biotech
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-16
- Primary completion
- 2016-05-11
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.